https://staging.norapharma.ca/norapharma-entente-lancement-biosimilaire/2022-02-01T12:33:57-05:00https://staging.norapharma.ca/norapharma-agreement-launch-biosimilar-canada/2022-02-01T12:40:31-05:00https://staging.norapharma.ca/nora-pharma-poursuit-son-elan-de-croissance-en-faisant-lacquisition-dactifs-de-pharmapar/2022-03-01T09:45:46-05:00https://staging.norapharma.ca/nora-pharma-continues-its-growth-momentum-by-acquiring-assets-of-pharmapar/2022-03-01T09:50:02-05:00https://staging.norapharma.ca/sunshine-biopharma-acquiert-nora-pharma-une-compagnie-pharmaceutique-canadienne-en-pleine-emergence/2023-06-19T08:20:33-05:00https://staging.norapharma.ca/sunshine-biopharma-announces-the-acquisition-of-nora-pharma-adding-10-7-million-in-revenue/2023-06-19T08:29:17-05:00https://staging.norapharma.ca/application-spontanee/2023-03-09T17:19:40-05:00https://staging.norapharma.ca/nora-pharma-recoit-lapprobation-de-sante-canada-pour-niopeg-un-biosimilaire-de-neulasta/2024-04-19T10:57:21-05:00https://staging.norapharma.ca/nora-pharma-receives-health-canada-approval-for-niopeg-a-biosimilar-of-neulasta/2024-04-19T11:00:38-05:00https://staging.norapharma.ca/cercle-des-futurs-associes-besoin-de-conseils-bancaires/2024-12-13T10:02:39-05:00https://staging.norapharma.ca/un-nouveau-chapitre-pour-nora-pharma-catherine-peloquin-prend-le-relais-a-la-presidence/2025-09-25T15:21:02-05:00https://staging.norapharma.ca/a-new-chapter-for-nora-pharma-catherine-peloquin-takes-over-as-president/2025-09-25T15:31:19-05:00